Purpose: Usual laparoscopic surgery of localized prostate cancer uses antegrade dissection. We describe and evaluate the original RELP (Retrograde Extraperitoneal Laparoscopic Prostatectomy). Materials and Methods: A prospective cohort of 1005 patients with clinically localized cancer prostate who were operated on from December 1999 to September 2013, in Lyon (France), and followed up to 172 months (median: 60 months). Patients encountered a RELP procedure, a totally extra-peritoneal approach with a retrograde dissection from the apex to the bladder neck, and ascending dissection of the erectile neurovascular bundles, facilitated by the 30° optic telescope. Adjunctive treatments were: immediate radiotherapy (9. 2%), salvage radiotherapy (13. 4%), androgen deprivation therapy (10. 8%), chemotherapy (1. 4%), no treatment (75. 8%). Results: The mean age was 63. 4 years, the Gleason score was 4+3 or worse in 24. 9%, there were 2. 3% unifocal tumors. The pathology stages were pT2A (8. 71%), pT2B (2. 80%), pT2C (69. 0%), pT3A (13. 1%), and pT3B (6. 41%). There were 60. 8% negative margins (R0) in total (90. 1% for basal locations, and 75. 8% for apical locations). The mean operating time was 115 minutes for the last 100 patients. The BPFSR (biological progression free survival rate, PSA ≤ 0. 10 ng/ml) was 71. 9% at 5 years, and 61. 4% at 10 years. The cancer specific survival rate was 99. 4% at 5 years, and 98. 3% at 10 years. After 12 months, 88. 6% of patients did not require an incontinence pad, and 67. 0% retained the pre-operative quality of their erection. Conclusion: RELP yields good oncologic results and quality of life, as good as robot-assisted surgery.